Editorial
1
CORRESPONDENCE
Volume 6, Issue 1 · pp. i-i · 2013 · DOI:
ABSTRACT
Dear Readers, As we all know, the concept of health insurance is very strong in the western world and like other systems, health insurance also got migrated to India and became popular but there are many parts in India where the traditional healthcare system prevails. India's growth has created substantial economic burden on the common man as there is a price hike in almost every aspect of living. The cost of prescription drugs has become vital component of almost every family's budget. India is called world's pharmacy as it supplies bulk medicine and cheaper life-saving medicines like antiretroviral medicines (ARVs) for HIV treatment, malaria and tuberculosis treatments to the developing countries. This has been possible because there were no patents until 2005. India started granting medicine patents from 2005 to comply with WTO under which the life of a patent is 20 years. Patented (branded) medicines are generally expensive due to lack of competition. When there is lack of availability of generics, if the brand producers are able to meet the shortage, question could be: Would the average consumer be able to afford the branded drugs?
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Hiremath, S. R. R. (2013). Editorial. Indian Journal of Pharmacy Practice, 6(1), i-i.
Copyright and licence
© 2013 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0